Inventor
TEDFORD CLARK E
US25 patents
⚠️ This page may combine multiple inventors who share the name “TEDFORD CLARK E”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
OMEROS CORP
9 patentsUS7919094B2Apr 5, 2011
Methods for treating conditions associated with MASP-2 dependent complement activation
OMEROS CORP86 citations95
US9066856B2Jun 30, 2015
Stable preservative-free mydriatic and anti-inflammatory solutions for injection
OMEROS CORP15 citations92
US9475885B2Oct 25, 2016
Compositions for inhibiting MASP-2 dependent complement activation
OMEROS CORP15 citations91
US9855246B2Jan 2, 2018
Stable preservative-free mydriatic and anti-inflammatory solutions for injection
OMEROS CORP9 citations84
US9486406B2Nov 8, 2016
Stable preservative-free mydriatic and anti-inflammatory solutions for injection
OMEROS CORP10 citations84
US11884742B2Jan 30, 2024
Methods for treating conditions associated with MASP-2 dependent complement activation
OMEROS CORP0 citations62
US11613589B2Mar 28, 2023
Compositions for inhibiting MASP-2 dependent complement activation
OMEROS CORP0 citations61
US10683367B2Jun 16, 2020
Compositions for inhibiting MASP-2 dependent complement activation
OMEROS CORP0 citations51
US10047165B2Aug 14, 2018
Compositions for inhibiting MASP-2 dependent complement activation
OMEROS CORP0 citations51
GLIATECH INC
6 patentsUS6448282B1Sep 10, 2002
1H-4(5)-substituted imidazole derivatives
GLIATECH INC29 citations91
US6166060ADec 26, 2000
1H-4(5)-substituted imidazole derivatives
GLIATECH INC19 citations91
US6008240ADec 28, 1999
2-(1H-4(5)-imidazoyl) cyclopropyl derivatives
GLIATECH INC17 citations82
US5990317ANov 23, 1999
2-(1H-4(5)-imidazoyl) cyclopropyl compounds
GLIATECH INC11 citations71
US5652258AJul 29, 1997
2-(4-imidazoyl) cyclopropyl derivatives
GLIATECH INC8 citations71
US6072057AJun 6, 2000
1H-4(5)-cyclo-substituted imidazole derivatives as histamine H3 receptor agents
GLIATECH INC1 citations50
LUMITHERA INC
5 patentsUS10881550B2Jan 5, 2021
Multi-wavelength phototherapy systems and methods for the treatment of damaged or diseased tissue
LUMITHERA INC12 citations93
US10219944B2Mar 5, 2019
Devices and methods for non-invasive multi-wavelength photobiomodulation for ocular treatments
LUMITHERA INC15 citations93
US12336937B2Jun 24, 2025
Multi-wavelength phototherapy devices, systems, and methods for the non-invasive treatment of damaged or diseased tissue
LUMITHERA INC3 citations73
US10596037B2Mar 24, 2020
Devices and methods for non-invasive multi-wavelength photobiomodulation for ocular treatments
LUMITHERA INC3 citations72
US12390658B2Aug 19, 2025
Methods for treating ocular disease
LUMITHERA INC0 citations51
SCHWAEBLE HANS-WILHELM
2 patentsUS8652477B2Feb 18, 2014
Methods for treating disseminated intravascular coagulation by inhibiting MASP-2 dependent complement activation
SCHWAEBLE HANS-WILHELM61 citations95
US8840893B2Sep 23, 2014
Methods for treating conditions associated with MASP-2 dependent complement activation
SCHWAEBLE HANS-WILHELM36 citations92